Kosuke Dodo Selected Research

benzohydrol (benzhydrol)

5/2015	Structure-activity relationships of benzhydrol derivatives based on 1'-acetoxychavicol acetate (ACA) and their inhibitory activities on multiple myeloma cell growth via inactivation of the NF-κB pathway.
10/2008	Structural development of benzhydrol-type 1'-acetoxychavicol acetate (ACA) analogs as human leukemia cell-growth inhibitors based on quantitative structure-activity relationship (QSAR) analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kosuke Dodo Research Topics

Disease

7	Neoplasms (Cancer) 10/2022 - 09/2008
4	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 01/2020 - 03/2013
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 03/2013
3	Necrosis 03/2018 - 10/2010
3	Leukemia 05/2015 - 06/2005
2	Bacterial Infections (Bacterial Infection) 01/2018 - 05/2017
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 03/2011 - 10/2010
1	Neoplasm Metastasis (Metastasis) 10/2016
1	Multiple Myeloma 05/2015
1	Fabry Disease (Fabry's Disease) 09/2013
1	Cystic Fibrosis (Mucoviscidosis) 09/2013
1	Inborn Genetic Diseases (Disease, Hereditary) 09/2013
1	Osteitis Deformans (Paget's Disease of Bone) 02/2013
1	Reperfusion Injury 11/2012
1	Vaccinia 04/2011

Drug/Important Bio-Agent (IBA)

3	CholesterolIBA 01/2020 - 03/2013
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 03/2013
2	alpha-Linolenic Acid (Linolenic Acid)IBA 10/2022 - 03/2021
2	coronatineIBA 01/2018 - 05/2017
2	Virulence Factors (Pathogenicity Factors)IBA 01/2018 - 05/2017
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017 - 03/2013
2	benzohydrol (benzhydrol)IBA 05/2015 - 10/2008
2	Biological ProductsIBA 05/2015 - 10/2010
2	1'-acetoxychavicol acetateIBA 05/2015 - 10/2008
2	Rhodopsin (Visual Purple)IBA 03/2011 - 10/2010
2	TeaIBA 02/2009 - 09/2008
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 02/2009 - 09/2008
1	StearatesIBA 10/2022
1	LipidsIBA 10/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2022
1	Alkynes (Acetylenes)IBA 10/2022
1	Oleic Acid (Oleate)IBA 10/2022
1	OxysterolsIBA 01/2020
1	Fas Ligand Protein (Fas Ligand)IBA 03/2018
1	Cystine (L-Cystine)IBA 11/2017
1	jasmonic acid (jasmonate)IBA 05/2017
1	Pharmaceutical PreparationsIBA 10/2016
1	Cathepsin BIBA 10/2016
1	Cysteine Proteases (Cysteine Protease)IBA 10/2016
1	2- (1H- indol- 3- yl)- 3- pentylamino- maleimideIBA 01/2016
1	3-amino-2-indolyllactamIBA 01/2016
1	LigandsIBA 09/2013
1	Mutant Proteins (Protein, Mutant)IBA 09/2013
1	oxidized low density lipoproteinIBA 03/2013
1	Calcitriol Receptors (Calcitriol Receptor)IBA 02/2013
1	AmidesIBA 11/2012
1	HydantoinsIBA 11/2012
1	Phosphates (Orthophosphate)IBA 04/2011
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 04/2011
1	Cardiotonic Agents (Cardiac Stimulants)IBA 10/2010
1	Phosphotransferases (Kinase)IBA 10/2010
1	Growth InhibitorsIBA 10/2008
1	maleimideIBA 06/2005

Therapy/Procedure

1	Therapeutics 01/2020